Question 1

How many shares of SYRE does VOLORIDGE INVESTMENT MANAGEMENT, LLC own?

Accepted Answer

VOLORIDGE INVESTMENT MANAGEMENT, LLC previously held 0 shares of SYRE (Spyre Therapeutics, Inc) before exiting the position in 2025-Q4.

Question 2

What is VOLORIDGE INVESTMENT MANAGEMENT, LLC's SYRE position worth?

Accepted Answer

VOLORIDGE INVESTMENT MANAGEMENT, LLC's SYRE position was last reported at $0 in 2025-Q4 before the exit.

Question 3

Is VOLORIDGE INVESTMENT MANAGEMENT, LLC buying or selling SYRE?

Accepted Answer

In 2025-Q4, VOLORIDGE INVESTMENT MANAGEMENT, LLC exited their SYRE position entirely (-100.0% change in shares).

Question 4

When did VOLORIDGE INVESTMENT MANAGEMENT, LLC first buy SYRE?

Accepted Answer

Based on available 13F filings, VOLORIDGE INVESTMENT MANAGEMENT, LLC first reported a position in SYRE in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$31.88	0
2025-Q3	Decreased	264,317	-5.2%	$4.4M	0.0%	$16.36	0
2025-Q2	Increased	278,920	+8.3%	$4.2M	0.0%	$15.22	29
2025-Q1	Increased	257,432	+122.9%	$4.2M	0.0%	$17.94	43
2024-Q4	Decreased	115,470	-26.2%	$2.7M	0.0%	$22.54	0
2024-Q3	Decreased	156,481	-43.1%	$4.6M	0.0%	$28.49	0